About Samuel Blackman
Samuel Blackman is an independent director at Bonum Therapeutics.
Experience
This experience comes from Samuel Blackman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Samuel Blackman in the role, so the role may have started earlier or lasted longer.
GV
GV (Google Ventures) Current
Entrepreneur in Residence
2025 – Present
PF
Pediatric Brain Tumor Foundation Current
Board Member
2025 – Present
Bonum Therapeutics, Inc. Current
Independent Director
2024 – Present · Seattle, WA
Develops targeted protein medicines for people with cancer.
CC
CureSearch for Children's Cancer Current
Board Member
2022 – Present
DB
Day One Biopharmaceuticals Current
Founder and Strategic Advisor
2018 – Present
PI
Presage Biosciences, Inc. Current
Board Member
2018 – Present
LH
Litmus Health Current
Advisory Board Member
2016 – Present
NO
Notable
Scientific Advisor
2019 – 2024
MI
Mavupharma, Inc.
Head of Clinical Development
2018 – 2019
ST
Silverback Therapeutics
Senior Vice President, Head of Clinical Development
2016 – 2018
JT
Juno Therapeutics
Senior Medical Director
2014 – 2016
SG
Seattle Genetics
Executive Director, Head of Translational Medicine
2012 – 2014
GL
GlaxoSmithKline
Director, Oncology Early Clinical Development
2010 – 2012
ME
Merck
Associate Director - Experimental Medicine
2008 – 2010
TP
The Childrens Hospital of Philadelphia
Staff Physician
2008 – 2010
CR
Consumers Medical Resource
Physician Consultant
2007 – 2009
DI
Dana-Farber Cancer Institute
Attending Physician in Pediatric Oncology
2008
CB
Children's Hospital Boston
Fellow in Pediatric Oncology
2004 – 2006
AA
American Medical Association
Resident/Fellow Representative - Council on Scientific Affairs
2003 – 2006
CC
Cincinnati Children's Hospital Medical Center
Resident in Pediatrics
2001 – 2004
Key Colleagues at Startups
The people Samuel Blackman works with at each company, as listed on that company's latest Form D.
Bonum Therapeutics, Inc. · Form D, Apr 17, 2026
Samuel Bjork
Executive Chair
Monique Schiersing
Senior Investment Director, Roche Venture
Neela Patel
Chief Business Officer
JM
John McKearn
Director
Diane Hollenbaugh
Chief Scientific Officer
John Mulligan
Chief Executive Officer and director
Karl Handelsman
Founder & Managing Partner, Codon Capital, director
NW
Nicholas Walrod
Director
MM
Mitchell Mutz
Independent Director
Gaurav Aggarwal
Managing Partner, Vivo Capital and director